Finding Middle Ground On FDA
47:46–49:29 · 102s
Steve lays out a pragmatic stance: supplements need a consumer trust layer, while peptides face overregulation; the future is elevating quality N=1 data.
47:46–49:29 · 102s
Steve lays out a pragmatic stance: supplements need a consumer trust layer, while peptides face overregulation; the future is elevating quality N=1 data.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.